{
    "nct_id": "NCT04470544",
    "official_title": "RECOVER: Phase 2 Randomized, Double-Blind Trial TREating Hospitalized Patients With COVID-19 With Camostat MesilatE, a TMPRSS2 Inhibitor",
    "inclusion_criteria": "* Laboratory confirmed SARS-CoV-2 infection\n* Admitted to hospital for management of SARS-CoV-2\n* Age ≥18\n* Subject or legal representative able to give informed consent\n* Ability to take all study drugs\n* Respiratory status of 3 or greater on the WHO ordinal scale\n* ALT or AST ≤5 x ULN\n* Creatinine clearance ≥50 mL/min using the Cockroft-Gault formula\n* Willingness to provide mandatory specimens for correlative research and banking\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Women who are pregnant or breastfeeding\n* Known hypersensitivity to the study drug, the metabolites or formulation excipient",
    "miscellaneous_criteria": ""
}